Biogen Idec, Inc. (NASDAQ:BIIB)
| CAPS Rating |
|
|---|---|
| Open | $120.04 |
| Previous Close | $119.60 |
| Daily Range | $116.63 - $120.04 |
| 52-Week Range | $65.39 - $123.23 |
| Market Cap | $28.57B |
| P/E Ratio | 22.80 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 2,089,780 |
| Average Daily Volume | 0 |
BIIB
VS S&P 500 (SPY)
How do you think BIIB will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BIIB Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BIIB News and Commentary
- 3 Biotechnology Stocks for Short-Term Traders – NASDAQ
- Forget Big Pharma, It Is Time For A Biotech ETF - ETF News And Commentary – NASDAQ
- Biogen: Government Investigating Company's Promotional Practices – SmartMoney
- Has Elan Become the Perfect Stock? – The Motley Fool
- How Many Stocks Should You Own? - Investment Ideas – NASDAQ
- The Disadvantage of a Successful Pipeline – The Motley Fool
- The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche - Press Releases – NASDAQ
- EPS Beat for Biogen; Outlook Weak - Analyst Blog – NASDAQ
- Biogen Idec Outruns Estimates Again – The Motley Fool
- 2nd UPDATE: Biogen 4Q Net Up 25%; Investing In Pipeline – SmartMoney
- 3 Swing Trade Setups in BIIB, XL and AIZ – Blog at The Motley Fool
- UPDATE: Biogen 4Q Net Up 25% As Company Invests In Pipeline – SmartMoney
- This Blockbuster Drug Just Got Better – The Motley Fool
- Biogen 4Q Profit Up 25% On Tysabri Sales Growth; Year View Weak – SmartMoney
- Which Big Biotech Is the Best Bet? – The Motley Fool
- Hasn't Cell Therapeutics Ever Heard of All-Nighters? – The Motley Fool
- Biogen & Elan Announce Tysabri Trial - Analyst Blog – NASDAQ
- Earnings Preview: Biogen - Analyst Blog – NASDAQ
- Label Expansion for Merck KGaA Drug - Analyst Blog – NASDAQ
- Label Expansion for Merck KGaA Drug - Analyst Blog – NASDAQ
RSS Headlines
Fool UK
